Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID‐19; a retrospective cohort study-Reference-Cited by-同舟云学术

Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID‐19; a retrospective cohort study

Published:2021-06-12 Issue:9 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Haji Aghajani Mohammad¹,Moradi Omid²^ORCID,Azhdari Tehrani Hamed³,Amini Hossein²,Pourheidar Elham²,Hatami Firouze⁴,Rabiei Mohammad Mahdi⁴,Sistanizad Mohammad¹²^ORCID

Affiliation:

1. Prevention of Cardiovascular Disease Research Center Imam Hossein HospitalShahid Beheshti University of Medical Sciences Tehran Iran

2. Department of Clinical Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran

3. Department of Hematology and Medical Oncology Shahid Beheshti University of Medical Sciences Tehran Iran

4. Clinical Research Development Unit of Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran

Funder

Shahid Beheshti University of Medical Sciences

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14434

Reference30 articles.

1. World Health Organization.WHO coronavirus disease (COVID‐19) dashboard.2021.https://covid19.who.int/. Accessed January 20 2021.

2. Immunopathology of Hyperinflammation in COVID-19

3. COVID-19 and the cardiovascular system

4. COVID-19-associated vasculitis and vasculopathy

5. Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the use of statins and in-hospital mortality risk in patients with sepsis-induced coagulopathy during ICU stays: a study based on medical information mart for intensive care database;BMC Infectious Diseases;2024-07-25

2. Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial;Respiratory Research;2024-02-22

3. A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin;Microorganisms;2024-02-13

4. Atorvastatin for Reduction of 28-day Mortality in Sever and Critical COVID-19 Patients: A Randomized Controlled Trial;2023-02-24

5. Statins: Beneficial Effects in Treatment of COVID-19;Advances in Experimental Medicine and Biology;2023